154 related articles for article (PubMed ID: 35298121)
1. Pushing the Limits on the Intestinal Crossing of Metal-Organic Frameworks: An
Rojas S; Hidalgo T; Luo Z; Ávila D; Laromaine A; Horcajada P
ACS Nano; 2022 Apr; 16(4):5830-5838. PubMed ID: 35298121
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers.
Hidalgo T; Giménez-Marqués M; Bellido E; Avila J; Asensio MC; Salles F; Lozano MV; Guillevic M; Simón-Vázquez R; González-Fernández A; Serre C; Alonso MJ; Horcajada P
Sci Rep; 2017 Mar; 7():43099. PubMed ID: 28256600
[TBL] [Abstract][Full Text] [Related]
3. Ti-Based nanoMOF as an Efficient Oral Therapeutic Agent.
Rojas S; Guillou N; Horcajada P
ACS Appl Mater Interfaces; 2019 Jun; 11(25):22188-22193. PubMed ID: 31140777
[TBL] [Abstract][Full Text] [Related]
4. Metal-Organic Framework Microsphere Formulation for Pulmonary Administration.
Fernández-Paz C; Rojas S; Salcedo-Abraira P; Simón-Yarza T; Remuñán-López C; Horcajada P
ACS Appl Mater Interfaces; 2020 Jun; 12(23):25676-25682. PubMed ID: 32364369
[TBL] [Abstract][Full Text] [Related]
5. Improving the genistein oral bioavailability
Botet-Carreras A; Tamames-Tabar C; Salles F; Rojas S; Imbuluzqueta E; Lana H; Blanco-Prieto MJ; Horcajada P
J Mater Chem B; 2021 Mar; 9(9):2233-2239. PubMed ID: 33596280
[TBL] [Abstract][Full Text] [Related]
6. Biocompatible porous metal-organic framework nanoparticles based on Fe or Zr for gentamicin vectorization.
Unamuno X; Imbuluzqueta E; Salles F; Horcajada P; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2018 Nov; 132():11-18. PubMed ID: 30179739
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
[TBL] [Abstract][Full Text] [Related]
8. Nanoscale Iron-Based Metal-Organic Frameworks: Incorporation of Functionalized Drugs and Degradation in Biological Media.
Christodoulou I; Lyu P; Soares CV; Patriarche G; Serre C; Maurin G; Gref R
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834775
[TBL] [Abstract][Full Text] [Related]
9. Amino modified metal-organic frameworks as pH-responsive nanoplatforms for safe delivery of camptothecin.
Cabrera-García A; Checa-Chavarria E; Rivero-Buceta E; Moreno V; Fernández E; Botella P
J Colloid Interface Sci; 2019 Apr; 541():163-174. PubMed ID: 30685611
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles of Metal-Organic Frameworks: On the Road to In Vivo Efficacy in Biomedicine.
Simon-Yarza T; Mielcarek A; Couvreur P; Serre C
Adv Mater; 2018 Sep; 30(37):e1707365. PubMed ID: 29876985
[TBL] [Abstract][Full Text] [Related]
11. Copper-olsalazine metal-organic frameworks as a nanocatalyst and epigenetic modulator for efficient inhibition of colorectal cancer growth and metastasis.
Li J; Zhang Z; Li J; Cun JE; Pan Q; Gao W; Luo K; He B; Gu Z; Pu Y
Acta Biomater; 2022 Oct; 152():495-506. PubMed ID: 36087871
[TBL] [Abstract][Full Text] [Related]
12. Emerging advances and current applications of nanoMOF-based membranes for water treatment.
Attia MS; Youssef AO; Abou-Omar MN; Mohamed EH; Boukherroub R; Khan A; Altalhi T; Amin MA
Chemosphere; 2022 Apr; 292():133369. PubMed ID: 34953879
[TBL] [Abstract][Full Text] [Related]
13. Advanced Characterization Methodology to Unravel the Biodegradability of Metal-Organic Framework Nanoparticles in Extremely Diluted Conditions.
Christodoulou I; Patriarche G; Serre C; Boissiére C; Gref R
ACS Appl Mater Interfaces; 2024 Mar; 16(11):14296-14307. PubMed ID: 38452344
[TBL] [Abstract][Full Text] [Related]
14. Heparin-engineered mesoporous iron metal-organic framework nanoparticles: toward stealth drug nanocarriers.
Bellido E; Hidalgo T; Lozano MV; Guillevic M; Simón-Vázquez R; Santander-Ortega MJ; González-Fernández Á; Serre C; Alonso MJ; Horcajada P
Adv Healthc Mater; 2015 Jun; 4(8):1246-57. PubMed ID: 25771896
[TBL] [Abstract][Full Text] [Related]
15. Porous nanoparticles with engineered shells release their drug cargo in cancer cells.
Qiu J; Li X; Rezaei M; Patriarche G; Casas-Solvas JM; Moreira-Alvarez B; Costa Fernandez JM; Encinar JR; Savina F; Picton L; Vargas-Berenguel A; Gref R
Int J Pharm; 2021 Dec; 610():121230. PubMed ID: 34718091
[TBL] [Abstract][Full Text] [Related]
16. Metal-organic framework based drug delivery systems as smart carriers for release of poorly soluble drugs hydrochlorothiazide and dapsone.
Yadav P; Bhardwaj P; Maruthi M; Chakraborty A; Kanoo P
Dalton Trans; 2023 Aug; 52(33):11725-11734. PubMed ID: 37555452
[TBL] [Abstract][Full Text] [Related]
17. Nanoscaled Metal-Organic Frameworks: Challenges Towards Biomedical Applications.
Oggianu M; Mameli V; Monni N; Ashoka Sahadevan S; Sanna Angotzi M; Cannas C; Mercuri ML
J Nanosci Nanotechnol; 2021 May; 21(5):2922-2929. PubMed ID: 33653459
[TBL] [Abstract][Full Text] [Related]
18. A "green" strategy to construct non-covalent, stable and bioactive coatings on porous MOF nanoparticles.
Agostoni V; Horcajada P; Noiray M; Malanga M; Aykaç A; Jicsinszky L; Vargas-Berenguel A; Semiramoth N; Daoud-Mahammed S; Nicolas V; Martineau C; Taulelle F; Vigneron J; Etcheberry A; Serre C; Gref R
Sci Rep; 2015 Jan; 5():7925. PubMed ID: 25603994
[TBL] [Abstract][Full Text] [Related]
19. Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells.
Yang B; Shen M; Liu J; Ren F
Pharm Res; 2017 Nov; 34(11):2440-2450. PubMed ID: 28887609
[TBL] [Abstract][Full Text] [Related]
20. A γ-cyclodextrin-based metal-organic framework (γ-CD-MOF): a review of recent advances for drug delivery application.
Hamedi A; Anceschi A; Patrucco A; Hasanzadeh M
J Drug Target; 2022 Apr; 30(4):381-393. PubMed ID: 34847807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
